Navigation Links
POET Announces That Cellulosic Ethanol Pilot Facility Will Be Operational This Year
Date:8/13/2008

Production of cellulosic ethanol in Scotland, S.D. to start in Q4 '08.

Sioux Falls, S.D. (Vocus) August 13, 2008 -- At the American Coalition for Ethanol conference, http://www.poet.com [POET] announced that construction will be completed on a $4 million pilot-scale cellulosic ethanol production facility later this year. The pilot plant will be adjacent to POET's corn ethanol pilot facility and a nine million gallon per year (MGPY) ethanol production facility in Scotland, S.D. It will allow POET to build upon recent technology advances before starting construction on www.projectliberty.com [Project LIBERTY], their commercial cellulosic production facility, next year.

"Our expanded research effort has led to several significant strides in the development of cellulosic ethanol technology at the lab scale in recent months," said Jeff Broin, CEO of POET. "Construction of this pilot facility will allow our company to take the next step toward the commercialization of cellulosic ethanol."

Broin also said that he is more confident about the future of cellulosic ethanol than ever before. "In the past few months, our scientists have been able to achieve significant ethanol percentages in fermentation and improve the yield of ethanol from biomass. Additionally, in our work with farmers and agricultural equipment manufacturers, we had a very successful harvest of corn cobs last fall and anticipate further advances during an expanded harvest this fall."

During the 2007 harvest, POET worked with major agricultural equipment manufacturers to harvest 4,000 acres of corn grain and cobs from a farmer's field in Southeastern South Dakota. Cobs from this fall's harvest and last will serve as the feedstock for the cellulosic p
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email: